Abstract
Ankylosing Spondylitis (AS) is a highly heritable inflammatory arthritis which occurs more frequently in men than women. In their recent publication examining sex differences in the genetic aetiology of common complex traits and diseases, Bernabeu et al. (2021) observe differences in heritability of AS between sexes, and a genome-wide significant genotype by sex interaction in risk of AS at the major histocompatability (MHC) locus1. The authors then present evidence suggesting that this genotype by sex interaction arises primarily as a result of differential expression of the gene MICA across the sexes in skeletal muscle tissue. Through a series of conditional association analyses in the UK Biobank, reanalysis of the GTEx gene expression resource and RNASeq experiments on peripheral blood cells from AS cases and controls, we show that the genotype by sex interaction the authors’ report is unlikely to be a result of variation in MICA, but probably reflects a known interaction between the HLA-B gene, sex and risk of AS. We demonstrate that the diagnostic accuracy of AS in the UK Biobank is low, particularly amongst women, likely explaining some of the observed differences in heritability across the sexes and the difficulty in precisely locating association signals in the cohort.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
D.M.E. is funded by an Australian National Health and Medical Research Council Senior Research Fellowship (APP1137714). A.F.M is funded by an Australian Research Council Future Fellowship (FT200100837). G.W. is supported by the University of Queensland Graduate School Scholarship (UQGSS). Z.L. is funded by Queensland University of Technology Vice-chancellor Reseach Fellowship.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics approval for collection of blood samples was granted by the Princess Alexandra Hospital and the Queensland University of Technology (QUT) Ethics Committees (Metro South approval no. HREC/05/QPAH/221 and QUT approval no. 1600000162). The UK Biobank has ethical approval from the North West Multi-Centre Research Ethics Committee (MREC), which covers the UK, and all participants provided written informed consent.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
ARISING FROM E Bernabeu et al Nature Genetics doi: https://doi.org/10.1038/s41588-021-00912-0 (2021)
Data Availability
This research has been conducted using the UK Biobank resource (References 53641 and 21024). We thank the participants of UK Biobank for making this work possible. The UK Biobank genotype and phenotype data are available by application from https://www.ukbiobank.ac.uk/. GTEx data are available upon application through dbGAP as described at https://gtexportal.org/home/datasets.
